Episode Details

Telehealth brands are scaling faster than ever — and getting kicked off Klaviyo faster than ever, too. In this episode, host Mark Militant breaks down the compliance gray area that's catching up with fast-growing telehealth startups: Klaviyo (and most ESPs) aren't HIPAA compliant, and once your revenue starts climbing, that target on your back gets a lot bigger.

Inspired by a recent post from Daniel Budai about a peptide client's migration headache, Mark walks through why this matters, when it starts to matter, and the three enterprise-grade platforms he's recommending to clients right now: Braze, HubSpot Enterprise, and Salesforce Marketing Cloud. He covers the real cost of compliance (spoiler: $35K/year minimum), why brands like Ro, Hims & Hers, and CVS run on Braze, and the lawsuit risk waiting for any telehealth brand marketing to patients without a BAA in place.

If you're building in telehealth — or thinking about it — this one's a must-listen before you send your next campaign.